首页> 外文OA文献 >Genetic vaccine for tuberculosis (pVAXhsp65) primes neonate mice for a strong immune response at the adult stage
【2h】

Genetic vaccine for tuberculosis (pVAXhsp65) primes neonate mice for a strong immune response at the adult stage

机译:结核病基因疫苗(pVaXhsp65)使新生小鼠在成人阶段获得强烈的免疫反应

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Abstract\ud \ud \ud \ud Background\ud \ud Vaccination of neonates is generally difficult due to the immaturity of the immune system and consequent higher susceptibility to tolerance induction. Genetic immunization has been described as an alternative to trigger a stronger immune response in neonates, including significant Th1 polarization. In this investigation we analysed the potential use of a genetic vaccine containing the heat shock protein (hsp65) from Mycobacterium leprae (pVAXhsp65) against tuberculosis (TB) in neonate mice. Aspects as antigen production, genomic integration and immunogenicity were evaluated.\ud \ud \ud \ud Methods\ud \ud Hsp65 message and genomic integration were evaluated by RT-PCR and Southern blot, respectively. Immunogenicity of pVAXhsp65 alone or combined with BCG was analysed by specific induction of antibodies and cytokines, both quantified by ELISA.\ud \ud \ud \ud Results\ud \ud This DNA vaccine was transcribed by muscular cells of neonate mice without integration into the cellular genome. Even though this vaccine was not strongly immunogenic when entirely administered (three doses) during early animal's life, it was not tolerogenic. In addition, pVAXhsp65 and BCG were equally able to prime newborn mice for a strong and mixed immune response (Th1 + Th2) to pVAXhsp65 boosters administered later, at the adult life.\ud \ud \ud \ud Conclusion\ud \ud These results suggest that pVAXhsp65 can be safely used as a priming stimulus in neonate animals in prime-boost similar strategies to control TB. However, priming with BCG or pVAXhsp65, directed the ensuing immune response triggered by an heterologous or homologous booster, to a mixed Th1/Th2 pattern of response. Measures as introduction of IL-12 or GM-CSF genes in the vaccine construct or even IL-4 neutralization, are probably required to increase the priming towards Th1 polarization to ensure control of tuberculosis infection.
机译:摘要由于免疫系统的不成熟以及对耐受性诱导的更高敏感性,通常很难对新生儿进行疫苗接种。基因免疫已被描述为在新生儿中引发更强的免疫反应的替代方法,包括明显的Th1极化。在这项研究中,我们分析了一种遗传疫苗的潜在用途,该疫苗含有来自麻风分枝杆菌(pVAXhsp65)的热休克蛋白(hsp65),可抗结核(TB)在新生小鼠中进行。评价了抗原产生,基因组整合和免疫原性等方面。分别通过RT-PCR和Southern印迹法评估了Hsp65信息和基因组整合。通过特异性的抗体和细胞因子诱导,分析了pVAXhsp65单独或与BCG的免疫原性,均通过ELISA定量。\ ud \ ud \ ud \ ud结果\ ud \ ud这种DNA疫苗是由新生小鼠的肌肉细胞转录而没有整合入细胞基因组。即使在动物的一生中完全接种(三剂)这种疫苗免疫力不强,它也不具有致耐受性。此外,pVAXhsp65和BCG同样能够引发新生小鼠对成年后后期施用的pVAXhsp65增强剂产生强而混合的免疫反应(Th1 + Th2)。\ ud \ ud \ ud \ ud结论\ ud \ ud结果表明,pVAXhsp65可以安全地用作新生动物中的引发刺激,以类似的控制结核的引发-加强策略进行。但是,用BCG或pVAXhsp65引发可将由异源或同源增强剂触发的随后的免疫反应导向混合的Th1 / Th2反应模式。可能需要采取措施,例如在疫苗构建物中引入IL-12或GM-CSF基因或什至IL-4中和,以增加对Th1极化的引发作用,以确保控制结核感染。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号